5 hours ago
1
magicmine/iStock via Getty Images
- Ascendis Pharma A/S (ASND) shared results from week 156 of its late-stage trial, showing that long-term use of TransCon PTH (palopegteriparatide) continues to be effective for adults with low parathyroid hormone levels.
- At this point in the study, the company said
English (US) ·